| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2009 | Acetylsalicylic acid regulates MMP-2 activity and inhibits colorectal invasion of murine B16F0 melanoma cells in C57BL/6J mice: effects of prostaglandin F(2)alpha. | Tsai, CS; Luo, SF; Ning, CC; Lin, CL; Jiang, MC; Liao, CF | Biomed Pharmacother 63(7), 522-527 | | | |
| 2008 | CAS enhances chemotherapeutic drug-induced p53 accumulation and apoptosis: use of CAS for high-sensitivity anticancer drug screening. | Liao, CF; Luo, SF; Tsai, CS; Tsao, TY; Chen, SL; Jiang, MC. | Toxicol. Mech. Method. 18, 771-776 | | | |
| 2012 | CSE1L, a Novel Microvesicle Membrane Protein, Mediates Ras-Triggered Microvesicle Generation and Metastasis of Tumor Cells. | Liao, CF; Lin, SH; Chen, HC; Tai, CJ; Chang, CC; Li, LT; Yeh, CM; Yeh, KT; Chen, YC; Hsu, TH; Shen, SC; Lee, WR; Chiou, JF; Luo, SF; Jiang, MC | MOLECULAR MEDICINE 18, 1269-80 | | | |
| 2008 | CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. | Liao, CF; Luo, SF; Shen, TY; Lin, CH; Chien, JT; Du, SY; Jiang, MC | BMB reports 41(3), 210-216 | | | |
| 2008 | CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. | Liao, CF; Luo, SF; Li, LT; Lin, CY; Chen, YC; Jiang, MC | Journal of experimental & clinical cancer research : CR 27, 15 | | | |
| 2009 | Overexpression of HO-1 Protects against TNF-{alpha}-Mediated Airway Inflammation by Down-Regulation of TNFR1-Dependent Oxidative Stress. | Lee, IT; Luo, SF; Lee, CW; Wang, SW; Lin, CC; Chang, CC; Chen, YL; Chau, LY; Yang, CM | Am J Pathol. 175, 519-532 | | | |
| 2007 | Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. | Jiang, MC; Luo, SF; Li, LT; Lin, CC; Du, SY; Lin, CY; Hsu, YW; Liao, CF | Journal of experimental & clinical cancer research : CR 26(1), 91-99 | | | |
| 2015 | Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study | Ko, TM ; Tsai, CY; Chen, SY; Chen, KS; Yu, KH; Chu, CS; Huang, CM; Wang, CR; Weng, CT; Yu, CL; Hsieh, SC; Tsai, JC; Lai, WT; Tsai, WC; Yin, GD; Ou, TT; Cheng, KH; Yen, JH; Liou, TL; Lin, TH; Chen, DY; Hsiao, PJ; Weng, MY; Chen, YM; Chen, CH; Liu, MF; Yen, HW; Lee, JJ; Kuo, MC; Wu, CC; Hung, SY; Luo, SF; Yang, YH; Chuang, HP; Chou, YC; Liao, HT; Wang, CW; Huang, CL; Chang, CS; Lee, MT ; Chen, P; Wong, CS; Chen, CH ; Wu, JY ; Chen, YT ; Shen, CY ; Taiwan Allopurinol-SCAR Consortium | BMJ-British Medical Journal 351, h4848 | | | |
